Search Results - "Queiroz, Marcello Moro"

18F-FDG PETCT and 68Ga-DOTA PETCT mismatch with in vivo histopathological characterization of low-grade neuroendocrine pancreatic tumor by Queiroz, Marcello Moro, Lopes, Carlos Diego Holanda, Salgues, Alessandra Corte Real, Barbosa, Felipe de Galiza, Abe, Emerson Shigueaki, Silveira, Thales Parenti, Machado, Marcel Cerqueira Cesar, Capareli, Fernanda Cunha

“…Background Pancreatic neuroendocrine tumor (PNET) is a subgroup of neuroendocrine tumor (NET) that has unique biology and natural history. The histological…”
Get full text

Management of In-Transit Metastases by Queiroz, Marcello Moro, Bertolli, Eduardo, Belfort, Francisco Aparecido, Munhoz, Rodrigo Ramella

“…Purpose of Review The purpose of this study is to discuss the current knowledge and future perspectives regarding the treatment options for in-transit…”
Get full text

Immunotherapy and Targeted Therapy for Advanced Biliary Tract Cancer: Adding New Flavors to the Pizza by Queiroz, Marcello Moro, Lima, Jr, Nildevande Firmino, Biachi de Castria, Tiago

“…Biliary tract cancers (BTCs) are a rare pathology and can be divided into four major subgroups: intrahepatic cholangiocarcinoma, extrahepatic…”
Get full text

AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings by Restini, Felipe Cicci Farinha, Torfeh, Tarraf, Aouadi, Souha, Hammoud, Rabih, Al-Hammadi, Noora, Starling, Maria Thereza Mansur, Sousa, Cecília Felix Penido Mendes, Mancini, Anselmo, Brito, Leticia Hernandes, Yoshimoto, Fernanda Hayashida, Lima-Júnior, Nildevande Firmino, Queiroz, Marcello Moro, Passos, Ula Lindoso, Amancio, Camila Trolez, Takahashi, Jorge Tomio, De Souza Delgado, Daniel, Hanna, Samir Abdallah, Marta, Gustavo Nader, Neves-Junior, Wellington Furtado Pimenta

“…Glioblastoma is an aggressive brain cancer with a poor prognosis. The O6-methylguanine-DNA methyltransferase (MGMT) gene methylation status is crucial for…”
Get full text

Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B by Reuter, Tania Queiroz, Gomes-Gouvea, Michele, Chuffi, Samira, Duque, Ulisses Horst, Carvalho, José Americo, Perini, Waltesia, Queiroz, Marcello Moro, Segal, Ingrid Marques, Azevedo, Raymundo Soares, Pinho, João Renato Rebello

“…Introduction and Objectives: Espírito Santo state is considered a region with a higher frequency of hepatitis B virus infection. This study characterized…”
Get full text

Gastrointestinal stromal tumors: advances in molecular characterization and therapeutic implications by Lima-Jr, Nildevande Firmino, Queiroz, Marcello Moro, Franco, Julia Sousa Leal, Lins-Junior, Domingos Savio do Rego, Campos, Eduardo Felício de, Awni, Beatriz Mendes, Lima, Luiz Guilherme Cernaglia Aureliano de, Teixeira, Frederico, Ferreira, Fábio de Oliveira, Akaishi, Eduardo Hiroshi, Capareli, Fernanda Cunha, Munhoz, Rodrigo Ramella

“…Recognition of the molecular basis of gastrointestinal stromal tumors has paved the way for significant breakthroughs in the diagnosis and treatment of this…”
Get full text

Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor by Queiroz, Marcello Moro, de Souza, Zenaide Silva, Gongora, Aline Bobato Lara, de Galiza Barbosa, Felipe, Buchpiguel, Carlos Alberto, de Castro, Marilia Germanos, de Macedo, Mariana Petaccia, Coelho, Rafael Ferreira, Sokol, Ethan Samuel, Camargo, Anamaria Aranha, Bastos, Diogo Assed

“…Immunotherapy has recently been incorporated into the treatment guidelines for metastatic urothelial carcinoma. Nevertheless, the role of prognostic and…”
Get full text

Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil by Queiroz, Marcello Moro, Sacardo, Karina Perez, Ribeiro, Mauricio Fernando, Gadotti, Luiza Lara, Saddi, Rodrigo, Oliveira, Leandro Jonata de Carvalho, Linck, Rudinei Diogo Marques, Cruz, Marcelo Rocha de Souza, Barroso-Sousa, Romualdo, Sahade, Marina, Correa, Tatiana Strava, Mano, Max Senna, Suzuki, Daniele Assad, Shimada, Andrea Kazumi, Katz, Artur

“…•Hormone receptor-positive HER2-negative metastatic breast cancer treatment changed drastically in recent years with the development of cyclin-dependent kinase…”
Get full text

Cardiovascular and thromboembolic events associated with intense neoadjuvant androgen deprivation therapy followed by prostatectomy in patients with localized prostate cancer: A meta-analysis of clinical trials by Campos, Eduardo Felicio, Xavier, Camila Bragança, Queiroz, Marcello Moro, Lima, Nildevande Firmino, Jardim, Denis L., Bastos, Diogo Assed, Ilario, Eder Nisi, Coelho, Rafael Ferreira, Nahas, William Carlos

“…341 Background: Several phase II trials have investigated neoadjuvant novel androgen receptor signaling inhibitors (ARSIs) in combination with androgen…”
Get full text

Impact of histopathological revision and molecular pathology in the diagnosis of sarcomas in a reference center in Brazil by Lopes, Carlos Diego Holanda, Queiroz, Marcello Moro, Sampaio, Luana Alencar Fernandes, Perina, Andre, Akaishi, Eduardo Hiroshi, Teixeira, Frederico Ribeiro, Ferreira, Fabio Oliveira, Hanna, Samir Abdallah, da Silva, Joao Luis, De Lima, Luiz Guilherme C. A., De Oliveira, Claudia Regina G. C. M., Munhoz, Rodrigo Ramella

“…e23533 Background: The accurate classification of sarcomas remains a major challenge due to the diversity and rarity of this group of mesenchymal tumors. In…”
Get full text

Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis by Felício de Campos, Eduardo, Xavier, Camila Bragança, Queiroz, Marcello Moro, Firmino Lima Júnior, Nildevande, Ilario, Eder Nisi, Coelho, Rafael Ferreira, Nahas, William Carlos, Bastos, Diogo Assed, Fontes Jardim, Denis Leonardo

“…•Cardiovascular and thromboembolic adverse events of intense neoadjuvant hormone therapy are underreported in clinical trials.•We conducted a systematic review…”
Get full text

Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report by de Castria, Tiago Biachi, Tang, Laura, Queiroz, Marcello Moro, Awni, Beatriz Mendes, Paroder, Viktoriya, Shamseddine, Ali, Bariani, Giovanni Mendonca, Mukherji, Deborah, Matar, Charbel F, Fernandes, Gustavo Dos Santos, El-Olayan, Ashwaq, Sabatin, Fouad, Elias, Rawad, Gupta, Ranju, Janjigian, Yelena Y, Abou-Alfa, Ghassan K

“…Hepatoid adenocarcinoma of the stomach is an uncommon subtype of gastric cancer remarkably similar to hepatocellular carcinoma in histopathological analysis…”
Get full text

Emerging biomarkers in metastatic urothelial carcinoma: tumour mutational burden, PD-L1 expression and APOBEC polypeptide-like signature in a patient with complete response to anti-programmed cell death protein-1 inhibitor by Queiroz, Marcello Moro, de Souza, Zenaide Silva, Gongora, Aline Bobato Lara, de Galiza Barbosa, Felipe, Buchpiguel, Carlos Alberto, de Castro, Marilia Germanos, de Macedo, Mariana Petaccia, Coelho, Rafael Ferreira, Sokol, Ethan Samuel, Camargo, Anamaria Aranha, Bastos, Diogo Assed

“…Immunotherapy has recently been incorporated into the treatment guidelines for metastatic urothelial carcinoma. Nevertheless, the role of prognostic and…”
Get full text

Hepatoid esophagogastric adenocarcinoma and tumoral heterogeneity: a case report by de Castria, Tiago Biachi, Tang, Laura, Queiroz, Marcello Moro, Awni, Beatriz Mendes, Paroder, Viktoriya, Shamseddine, Ali, Bariani, Giovanni Mendonca, Mukherji, Deborah, Matar, Charbel F, Fernandes, Gustavo Dos Santos, El-Olayan, Ashwaq, Sabatin, Fouad, Elias, Rawad, Gupta, Ranju, Janjigian, Yelena Y, Abou-Alfa, Ghassan K

Get full text